Mayo Clinic has launched an effort to promote collaborations between itself and Israeli startups. It will be managed by Mayo Clinic Ventures.
Intermountain Healthcare partners with, invests in Israeli startup for machine learning in radiology
The latest in a long lineup of efforts to introduce machine learning into medical imaging is a deal between Zebra Medical Vision and Intermountain Healthcare. The not-for-profit health system based in Salt Lake City, UT, includes 22 hospitals and more than 185 clinics; it expects that the deal will assist its radiologists with automated diagnostic algorithms.
GE Healthcare has partnered with Endra Life Sciences to develop the startup's Thermo-Acoustic Enhanced UltraSound. The aim is to develop ultrasound systems capable of imaging a variety of tissue functions and compositions as well as monitoring therapeutic interventions--at the point of care.
Varian Medical Systems' share price is virtually unchanged from two years ago. That's despite the growing consensus that its proton therapy offers more precise and less toxic treatment for cancer patients than traditional radiation. It's now planning to spin off its imaging components business to help unlock some of that value.
Automotive giant Toyota Motor is teaming up with Dean Kamen, the inventor of the Segway, to create a next-generation wheelchair for disabled people and the elderly. The move comes after Toyota announced last year that it would sink $1 billion into artificial intelligence and robotics.
Propeller Health has relied on dealmaking to expand in the smart inhaler field, and its latest move follows in the same vein. The company is partnering with Vectura Group to develop digitally connected sensors for chronic respiratory diseases.
Luminex was forced to raise its $58 million offer for molecular microbiology and diagnostics company Nanosphere to about $77 million after an unsolicited third party offered $1.50 per share.
Engineers at the University of California, San Diego, have staked a claim to being the first to create a wearable that can simultaneously monitor biochemical and electrical bodily signals. Their Chem-Phys patch simultaneously records both electrocardiograms (EKGs) and lactate, which is a biochemical marker that's a measure of physical effort.
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), which is part of the U.S. National Institutes of Health, issued a research challenge in March 2015 for the creation of a noninvasive, wearable alcohol biosensor. The expectation is that such a device would be useful to researchers who typically have to rely upon self-reported alcohol consumption data--as well as to make consumer wearables that monitor alcohol consumption commonplace.
Some high-risk women's health devices were approved without proper data, according to a recent study. The findings point to a need for increased oversight from the agency, researchers said.
Endo has agreed to shell out billions to settle most of the cases claiming injuries from its vaginal mesh devices. But don't expect the company to pay inflated damages for women who were encouraged to pursue unnecessary removal surgeries, it said.
B. Braun Medical has agreed to pay almost $8 million in penalties, forfeiture and restitution to resolve its criminal liability related to the sale of contaminated prefilled saline flush syringes that dates back to 2007.
Royal Philips, like many major medical device and imaging players, is looking to secure sizable long-term deals with hospitals. The idea is not only to secure future Philips revenues but also to cement a partnership that could result in more fruitful efforts at value-based healthcare, thereby meeting one of the most profound hospital needs.
Medtronic never intended to hide a study showing serious side effects linked to its Infuse bone graft, the company said in letters to two inquiring lawmakers. The company's response comes a month after reports showed that Medtronic pulled the plug on a study of its Infuse bone graft and allegedly buried the evidence.
Med tech is attracting a huge range of strategic investors right now. Healthcare is almost universally recognized as in need of rationalization--the application of technology in the effort to achieve better outcomes at lower costs. Medical devices and diagnostics, and the data that they generate, are expected to be central to achieving that goal in the coming decades.
Edwards Lifesciences' CardiAQ Valve Technologies scored a victory in a courtroom battle with a rival and former service provider that allegedly stole the company's trade secrets to develop its transcatheter mitral valves.
Urine tests are a staple at the doctor's office, but take time, cost money and can pile up quickly. Good news: Stanford University engineers are working on a low-cost, portable version of the test to ease the burden on doctors and clinics.
The Centers for Medicare and Medicaid Services (CMS) has started an analysis for a national coverage determination (NCD) for its coverage of leadless cardiac pacemakers.
The use of 3-D mammography to complement a standard 2-D approach in breast cancer screening is becoming more standard. But all previous FDA approvals of mammography systems have included a combination of both 3-D and 2-D approaches. Now, Siemens has nabbed the first FDA approval for a 3-D digital breast tomosynthesis system.
Despite all the innovation in med tech on so many fronts, it's often a slow process to see those efforts incorporated into patient care in a way that could improve their treatment and aid healthcare providers. Now, Hospira is debuting a device that seems a no-brainer in terms of making routine hospital care more efficient--and potentially safer.